The Federal Circuit recently weighed in on an interference proceeding between the University of California (“UC”) and the Broad Institute over the use of CRISPR-Cas9 technology. The Court affirmed a Patent Trial and Appeal Board (“Board”) decision finding there was no interference-in-fact between UC’s patent application and the claims of twelve patents and one application owned by Institute… Considering the evidence of simultaneous invention, along with evidence regarding the state of the art, inventor statements, and application of similar technologies, the Court concluded the Board’s finding was supported by substantial evidence.
The post Federal Circuit Affirms Board: No Interference-in-Fact for CRISPR-Cas9 Technology appeared first on IPWatchdog.com | Patents & Patent Law.
Recent Posts
- Let’s Get Grateful: IP Stakeholders Reveal What They Were Thankful for in 2024
- False USPTO Narratives and the Urgent Need for PTAB Reform
- SCOTUS Invites SG to Weigh in on Cox/ Sony Cases, Denies Petition Charging Newman’s Removal Harms Patent Owners
- We Want Your Input on Content for IPWatchdog’s PTAB 2025 Program
- Other Barks & Bites for Friday, November 22: USPTO Bans Employees from Using Generative AI for Work Purposes; WIPO Member States Adopt New Design Law Treaty; DOJ Proposes Google Must Sell Chrome